Sean McCutcheon
Stock Analyst at Raymond James
(4.37)
# 1,317
Out of 5,125 analysts
44
Total ratings
39.4%
Success rate
30%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $24 → $22 | $2.20 | +900.00% | 2 | Sep 9, 2026 | |
| XNCR Xencor | Rated: Buy | $40 → $46 | $39.39 | +16.78% | 2 | Sep 1, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $76 → $248 | $193.06 | +28.46% | 3 | Aug 27, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $11 | $1.60 | +589.66% | 3 | Aug 6, 2026 | |
| FTH Faeth Therapeutics | Initiated Coverage: Buy | $56 | $12.92 | +333.44% | 1 | Jul 31, 2026 | |
| RLAY Relay Therapeutics | Reiterated: Buy | $19 → $26 | $19.94 | +30.39% | 2 | May 19, 2026 | |
| ENGN enGene Therapeutics | Reiterated: Buy | $27 → $4 | $1.67 | +139.52% | 5 | May 8, 2026 | |
| CMPX Compass Therapeutics | Downgraded: Hold | n/a | $0.838 | - | 3 | Apr 28, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $12 → $19 | $13.15 | +44.49% | 4 | Feb 24, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $29 | $7.69 | n/a | 5 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $33.41 | n/a | 4 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $62.80 | n/a | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $916.06 | n/a | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $65 | $12.04 | n/a | 1 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 | $20.41 | n/a | 3 | Jun 13, 2025 |
BridgeBio Oncology Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $24 → $22
Current: $2.20
Upside: +900.00%
Xencor
Sep 1, 2026
Rated: Buy
Price Target: $40 → $46
Current: $39.39
Upside: +16.78%
Revolution Medicines
Aug 27, 2026
Reiterated: Buy
Price Target: $76 → $248
Current: $193.06
Upside: +28.46%
Black Diamond Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $11
Current: $1.60
Upside: +589.66%
Faeth Therapeutics
Jul 31, 2026
Initiated Coverage: Buy
Price Target: $56
Current: $12.92
Upside: +333.44%
Relay Therapeutics
May 19, 2026
Reiterated: Buy
Price Target: $19 → $26
Current: $19.94
Upside: +30.39%
enGene Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $27 → $4
Current: $1.67
Upside: +139.52%
Compass Therapeutics
Apr 28, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.838
Upside: -
Vir Biotechnology
Feb 24, 2026
Reiterated: Buy
Price Target: $12 → $19
Current: $13.15
Upside: +44.49%
REGENXBIO
Sep 5, 2025
Reiterated: Buy
Price Target: $29
Current: $7.69
Upside: n/a
Jul 24, 2025
Reiterated: Hold
Price Target: n/a
Current: $33.41
Upside: n/a
Jul 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $62.80
Upside: n/a
Jul 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $916.06
Upside: n/a
Jul 11, 2025
Initiated Coverage: Buy
Price Target: $65
Current: $12.04
Upside: n/a
Jun 13, 2025
Reiterated: Buy
Price Target: $86
Current: $20.41
Upside: n/a